Investors Urged to Seek Legal Counsel as Rafael Holdings Faces Investigation

Pomerantz Law Firm Probes Allegations Against Rafael Holdings, Inc.

On October 15, 2026, Pomerantz LLP announced an investigation concerning investors of Rafael Holdings, Inc. (NYSE: RFL). The firm is gathering information to determine if the company, along with some of its officers and directors, may have participated in unlawful business practices or securities fraud. This investigation comes on the heels of a troubling press release from Rafael that significantly impacted the company's stock price.

On September 30, 2026, Rafael issued a press release announcing the results of a pivotal Phase 3 study involving its Cyclo Therapeutics, LLC subsidiary. The study evaluated the efficacy and safety of its treatment, Trappsol® Cyclo™, for patients diagnosed with Niemann-Pick Disease Type C (NPC). Unfortunately, the results were less than favorable, as the primary endpoint did not reach statistical significance. Following this announcement, Rafael's stock price plummeted by nearly 35%, closing at $1.32 per share—a stark reflection of investor response to the unfavorable results.

Pomerantz LLP is encouraging individuals affected by this stock decline to reach out to the firm for potential representation. Those invested in Rafael Holdings may have suffered considerable losses, and the firm aims to help recover damages. Danielle Peyton, a representative from Pomerantz, is available to assist investors, who can contact her via email or phone.

Rafael Holdings has a history of innovative endeavours aimed at treating rare diseases, but the recent setback has raised questions regarding the company's practices. The firm was founded with a commitment to protecting investors' rights, and they are looking into whether Rafael’s executives acted in compliance with legal standards.

The legal implications of such investigations can be profound for both investors and the company itself. A finding of fraud or misconduct could lead to serious repercussions including financial penalties for the firm and possible legal consequences for its executives. Thus, the outcome of this investigation could have lasting impacts on Rafael Holdings as it navigates through this challenging period.

Pomerantz LLP has built a strong reputation over the past 85 years, known for its expertise in corporate and securities litigation, particularly in cases advocating for victims of fiduciary breaches and corporate wrongdoing. As a notable player in this legal arena, they emphasize the importance of investor awareness and action, especially when faced with uncertainties surrounding their investments.

The investigation process will likely take time as Pomerantz gathers relevant information and testimonies. Investors are advised to stay informed and consider their options as this story develops, particularly in light of the firm's history of recovering compensation for defrauded investors. Keeping lines of communication open with legal professionals can provide clarity and direction during such tumultuous times.

As the situation evolves, it's essential for stakeholders to remain vigilant, especially when facing stock price volatility resulting from public disclosures. The case of Rafael Holdings serves as a critical example for investors to heed the potential dangers and complexities of corporate governance and stock ownership, necessitating prudent measures and timely legal counsel when needed.

In conclusion, if you have invested in Rafael Holdings and are concerned about your rights and potential losses, don’t hesitate to reach out to Pomerantz LLP for assistance. Their extensive experience and commitment to investor advocacy could prove invaluable during this uncertain time.